The Institute Krems Bioanalytics played a central part in a study recently published by the laboratory of Christoph Wiesner in Cells, contributing advanced quantitative mass spectrometry and proteomics to uncover mechanisms of bone formation.
Using Data-Independent-Acquisition LC-MS/MS, the team performed deep proteome profiling of mesenchymal stem cells, enabling the identification of thousands of proteins and large-scale pathway changes linked to osteogenic differentiation.
Key proteomic findings include:
Identification of 958 differentially expressed proteins in TLR10-overexpressing cells
Detection of over 2,400 proteomic alterations following TLR10 suppression
Clear enrichment of pathways related to osteogenesis, extra cellular matrix remodeling, and vitamin D signaling
These data were crucial in demonstrating how the immune receptor TLR10 regulates stem cell differentiation into bone-forming cells, coordinating molecular programs required for matrix development and mineralization.
The study highlights the essential role of mass spectrometry-based proteomics in translating complex biological processes into actionable molecular insights—positioning Krems Bioanalytics as a key partner in cutting-edge life sciences research.
